GloPID-R Clinical Trials Working Group Roadmap referenced in recent joint statement
Through a joint statement on 25th September, 2025, some of the world’s largest funders of medical research have committed to implement WHO standards to strengthen clinical trials systems. The statement builds on the 2017 WHO Joint Statement on public disclosure of clinical trial results and references the 2023 GloPID-R Funders’ Roadmap for Clinical Trial Coordination, developed by the GloPID-R Clinical Trials Working Group.
This commitment aims to better align funders’ policies and practices, creating a more coordinated global trial ecosystem. It is expected to reduce duplication, improve the efficient use of research funds, and ensure that clinical evidence more accurately reflects the needs of diverse populations.
Within six months, signatories plan to develop a set of high-level, measurable indicators to track collective progress. These indicators will serve as a framework for accountability and transparency, helping to assess how effectively funders are delivering on their commitments.
